SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-22-000201
Filing Date
2022-02-14
Accepted
2022-02-14 16:12:37
Documents
2
Group Members
GILAD AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A phasebio_13ga1.htm SC 13G/A 135508
2 EXHIBIT A ex_a.htm EX-99.A 7036
  Complete submission text file 0001019056-22-000201.txt   144407
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90691 | Film No.: 22631977
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G/A